https://news.medxy.ai/ja/menopause-hormone-therapy-heart-risk/Medxy AIja2026-09-09T10:45:37-07:00閉経期ホルモン療法は中年女性の心血管リスクをどう変えるか：SWAN研究が示す血管運動症状との関連 https://news.medxy.ai/optimizing-patient-expectations-and-outcomes-understanding-days-alive-and-out-of-hospital-after-lung-transplantation/Medxy AIen2026-09-09T10:45:34-07:00Optimizing Patient Expectations and Outcomes: Understanding Days Alive and Out of Hospital After Lung Transplantation https://news.medxy.ai/vi/menopause-hormone-therapy-cvd-risk/Medxy AIvi2026-09-09T10:45:16-07:00Liệu pháp hormone mãn kinh và nguy cơ tim mạch ở phụ nữ trung niên có triệu chứng vận mạch: Góc nhìn từ nghiên cứu SWAN https://news.medxy.ai/zh/copd-stability/Medxy AIzh2026-09-09T10:45:01-07:00COPD疾病稳定性如何定义与实现：来自Ⅲ期试验的启示 https://news.medxy.ai/ja/copd-stability-2/Medxy AIja2026-09-09T10:44:45-07:00COPDの疾患安定性をどう定義し、どう達成するか：第3相試験からの示唆 https://news.medxy.ai/vi/copd-stability-goals/Medxy AIvi2026-09-09T10:44:24-07:00Xác định và đạt mục tiêu ổn định bệnh trong COPD: Những phân tích từ các thử nghiệm pha 3 https://news.medxy.ai/zh/hemoglobin-mortality-risk/Medxy AIzh2026-09-09T10:44:07-07:00血红蛋白水平与死亡风险：来自英国大型队列研究的启示 https://news.medxy.ai/defining-and-achieving-disease-stability-in-copd-insights-from-phase-3-trials/Medxy AIen2026-09-09T10:44:06-07:00Defining and Achieving Disease Stability in COPD: Insights from Phase 3 Trials https://news.medxy.ai/ja/hemoglobin-mortality-risk/Medxy AIja2026-09-09T10:43:48-07:00ヘモグロビン値と死亡リスク：英国大規模コホート研究が示す新たな知見 https://news.medxy.ai/zh/bronchiectasis-exacerbation-phenotype/Medxy AIzh2026-09-09T10:43:31-07:00支气管扩张症中“频繁急性加重者”表型需重新审视：来自 EMBARC 登记研究的启示 https://news.medxy.ai/vi/hemoglobin-mortality-risk/Medxy AIvi2026-09-09T10:43:30-07:00Nồng độ Hemoglobin và Nguy cơ Tử vong: Góc nhìn từ một Nghiên cứu Đoàn hệ Lớn tại Vương quốc Anh https://news.medxy.ai/ja/71917-2/Medxy AIja2026-09-09T10:43:14-07:00気管支拡張症における頻回増悪型（Frequent Exacerbator Phenotype）の再評価：EMBARCレジストリからの知見 https://news.medxy.ai/vi/frequent-exacerbation-bronchiectasis/Medxy AIvi2026-09-09T10:42:55-07:00Xem xét lại kiểu hình người kịch phát thường xuyên trong giãn phế quản: Góc nhìn từ cơ sở dữ liệu EMBARC https://news.medxy.ai/reevaluating-the-frequent-exacerbator-phenotype-in-bronchiectasis-insights-from-the-embarc-registry/Medxy AIen2026-09-09T10:42:37-07:00Reevaluating the Frequent Exacerbator Phenotype in Bronchiectasis: Insights from the EMBARC Registry https://news.medxy.ai/zh/atopic-disease-keratoconus/Medxy AIzh2026-09-09T10:42:01-07:00累积性特应性疾病负担与圆锥角膜：来自大规模横断面与纵向分析的启示 https://news.medxy.ai/zh/bcma-car-t-bridge/Medxy AIzh2026-09-09T10:41:50-07:00优化复发/难治性多发性骨髓瘤 BCMA 靶向 CAR T 细胞治疗前的桥接治疗：一项真实世界多中心分析 https://news.medxy.ai/ja/atopic-keratoconus/Medxy AIja2026-09-09T10:41:43-07:00累積アトピー性疾患負荷と角膜円錐症：大規模横断・縦断解析から見えてきた知見 https://news.medxy.ai/ja/bcma-car-t-therapy/Medxy AIja2026-09-09T10:41:31-07:00再発・難治性多発性骨髄腫におけるBCMA標的CAR-T療法前ブリッジング治療の最適化：リアルワールド多施設解析 https://news.medxy.ai/vi/atopy-keratoconus-burden/Medxy AIvi2026-09-09T10:41:22-07:00Gánh nặng bệnh atopy tích lũy và keratoconus: Góc nhìn từ các phân tích cắt ngang và dọc quy mô lớn https://news.medxy.ai/vi/car-t-therapy-optimization/Medxy AIvi2026-09-09T10:41:07-07:00Tối ưu hóa liệu pháp cầu nối trước điều trị CAR T hướng đích BCMA ở đa u tủy xương tái phát/kháng trị: Phân tích đa trung tâm trong thực hành thực tế https://news.medxy.ai/cumulative-atopic-disease-burden-and-keratoconus-insights-from-large-scale-cross-sectional-and-longitudinal-analyses/Medxy AIen2026-09-09T10:41:03-07:00Cumulative Atopic Disease Burden and Keratoconus: Insights from Large-Scale Cross-Sectional and Longitudinal Analyses https://news.medxy.ai/zh/obesity-dry-eye-gender/Medxy AIzh2026-09-09T10:40:15-07:00肥胖与干眼病的性别差异关联：来自大规模 UK Biobank 研究的启示 https://news.medxy.ai/zh/myeloproliferative-tumors-trends/Medxy AIzh2026-09-09T10:40:02-07:00骨髓增殖性肿瘤流行病学与生存趋势的演变：来自SEER 2000—2021年的观察 https://news.medxy.ai/ja/71902-2/Medxy AIja2026-09-09T10:39:58-07:00肥満とドライアイ疾患との性差のある関連：大規模UKバイオバンク研究からの知見 https://news.medxy.ai/ja/myeloproliferative-tumors/Medxy AIja2026-09-09T10:39:40-07:00骨髄増殖性腫瘍の疫学と生存の変遷：SEER 2000–2021からの知見 https://news.medxy.ai/vi/obesity-dry-eye/Medxy AIvi2026-09-09T10:39:38-07:00Béo phì và bệnh khô mắt: mối liên hệ khác nhau theo giới từ một nghiên cứu quy mô lớn của UK Biobank https://news.medxy.ai/sex-specific-associations-between-adiposity-and-dry-eye-disease-insights-from-a-large-uk-biobank-study/Medxy AIen2026-09-09T10:39:19-07:00Sex-Specific Associations Between Adiposity and Dry Eye Disease: Insights from a Large UK Biobank Study https://news.medxy.ai/vi/epigenetics-survival-trends/Medxy AIvi2026-09-09T10:39:17-07:00Dịch tễ học biến đổi và xu hướng sống còn trong nhóm tân sinh tăng sinh tủy: dữ liệu từ SEER giai đoạn 2000–2021 https://news.medxy.ai/zh/glaucoma-progression-detection/Medxy AIzh2026-09-09T10:38:36-07:00青光眼进展的事件驱动检测：整合 OCT、OCTA 与视野指标 https://news.medxy.ai/ja/glaucoma-progression/Medxy AIja2026-09-09T10:38:17-07:00緑内障の進行をイベントベースで捉える：OCT・OCT血管撮影・視野指標の統合 https://news.medxy.ai/zh/prmt9-aml-resistance/Medxy AIzh2026-09-09T10:38:07-07:00靶向 PRMT9：破解 AML 中 Venetoclax 耐药的新策略 https://news.medxy.ai/vi/glaucoma-progression-events/Medxy AIvi2026-09-09T10:37:55-07:00Phát hiện tiến triển glôcôm theo sự kiện: tích hợp OCT, OCTA và các chỉ số thị trường https://news.medxy.ai/ja/prmt9-targeting-aml/Medxy AIja2026-09-09T10:37:50-07:00AMLのベネトクラクス耐性を打破するPRMT9標的化――治療戦略を塗り替える可能性 https://news.medxy.ai/event-based-progression-detection-in-glaucoma-integrating-oct-oct-angiography-and-visual-field-metrics/Medxy AIen2026-09-09T10:37:33-07:00Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics https://news.medxy.ai/vi/72944-2/Medxy AIvi2026-09-09T10:37:30-07:00 https://news.medxy.ai/zh/71886-2/Medxy AIzh2026-09-09T10:36:38-07:00高度近视患者眼球三维形态的纵向变化及病理性后遗症：对个性化监测的启示 https://news.medxy.ai/zh/72941-2/Medxy AIzh2026-09-09T10:36:30-07:00 https://news.medxy.ai/ja/high-myopia-eye-shape/Medxy AIja2026-09-09T10:36:14-07:00高度近視における3次元眼球形状の縦断的変化と病的後遺症：個別化サーベイランスへの示唆 https://news.medxy.ai/ja/copd-astegolimab/Medxy AIja2026-09-09T10:36:06-07:00頻回増悪を伴うCOPDに対するアステゴリマブ：ALIENTOおよびARNASA併合試験からの知見 https://news.medxy.ai/vi/3d-eye-shape-myriasis/Medxy AIvi2026-09-09T10:35:54-07:00Quỹ đạo theo thời gian của hình dạng mắt 3 chiều và các di chứng bệnh lý trong cận thị nặng: hàm ý cho theo dõi cá thể hóa https://news.medxy.ai/vi/astegolimab-copd-exacerbations/Medxy AIvi2026-09-09T10:35:40-07:00Astegolimab trong bệnh phổi tắc nghẽn mạn tính kịch phát thường xuyên: Góc nhìn từ phân tích gộp ALIENTO và ARNASA https://news.medxy.ai/longitudinal-trajectories-of-3-dimensional-eye-shape-and-pathological-sequelae-in-high-myopia-implications-for-personalized-surveillance/Medxy AIen2026-09-09T10:35:33-07:00Longitudinal Trajectories of 3-Dimensional Eye Shape and Pathological Sequelae in High Myopia: Implications for Personalized Surveillance https://news.medxy.ai/zh/impact-of-research-output/Medxy AIzh2026-09-09T10:34:44-07:00专门研究年对耳鼻咽喉科住院医师申请者学术产出的真实影响有多大？ https://news.medxy.ai/ja/otolaryngology-research-impact/Medxy AIja2026-09-09T10:34:29-07:00耳鼻咽喉科レジデンシー志望者における専従研究年の真の効果を検証する https://news.medxy.ai/vi/impact-specialized-research/Medxy AIvi2026-09-09T10:34:12-07:00Đánh giá tác động thực sự của một năm nghiên cứu chuyên biệt đối với đầu ra học thuật của ứng viên nội trú Tai Mũi Họng https://news.medxy.ai/zh/post-cataract-endophthalmitis/Medxy AIzh2026-09-09T10:34:08-07:00白内障术后眼内炎的微生物谱演变与临床特征：一项23年回顾性队列研究 https://news.medxy.ai/evaluating-the-true-impact-of-a-dedicated-research-year-on-otolaryngology-residency-applicants-scholarly-output/Medxy AIen2026-09-09T10:33:56-07:00Evaluating the True Impact of a Dedicated Research Year on Otolaryngology Residency Applicants’ Scholarly Output https://news.medxy.ai/ja/72935-2/Medxy AIja2026-09-09T10:33:48-07:00 https://news.medxy.ai/vi/endophthalmitis-post-cataract-surgery/Medxy AIvi2026-09-09T10:33:25-07:00Viêm nội nhãn sau phẫu thuật đục thủy tinh thể: Phổ vi sinh biến đổi và đặc điểm lâm sàng từ một nghiên cứu đoàn hệ hồi cứu kéo dài 23 năm https://news.medxy.ai/zh/zenker-dysphagia/Medxy AIzh2026-09-09T10:33:17-07:00Zenker 憩室相关环咽肌功能障碍术后吞咽困难：持续性与复发性的区分——来自 POuCH 研究的启示 https://news.medxy.ai/ja/zenker-diverticulum-swallowing/Medxy AIja2026-09-09T10:32:57-07:00Zenker憩室合併輪状咽頭筋機能障害手術後の持続性・再発性嚥下障害をどう見分けるか：POuCH研究からの知見 https://news.medxy.ai/vi/dysphagia-differentiation/Medxy AIvi2026-09-09T10:32:35-07:00Phân biệt nuốt khó dai dẳng và nuốt khó tái phát sau phẫu thuật rối loạn chức năng cơ nhẫn hầu kèm túi thừa Zenker: Góc nhìn từ nghiên cứu POuCH https://news.medxy.ai/differentiating-persistent-and-recurrent-dysphagia-after-surgery-for-cricopharyngeal-muscle-dysfunction-with-zenker-diverticulum-insights-from-the-pouch-study/Medxy AIen2026-09-09T10:32:17-07:00Differentiating Persistent and Recurrent Dysphagia After Surgery for Cricopharyngeal Muscle Dysfunction with Zenker Diverticulum: Insights from the POuCH Study https://news.medxy.ai/zh/hearing-aid-compliance/Medxy AIzh2026-09-09T10:32:14-07:00破解小耳畸形儿童骨导听力设备依从性难题 https://news.medxy.ai/ja/bone-conduction-hearing-aid-adherence/Medxy AIja2026-09-09T10:31:55-07:00小耳症児における骨導補聴器アドヒアランス低下の要因を探る https://news.medxy.ai/zh/decompensated-cirrhosis-impact-2/Medxy AIzh2026-09-09T10:31:33-07:00失代偿性肝硬化对心脏外科手术结局的影响：临床与经济学意义 https://news.medxy.ai/vi/bone-conduction-hearing-aids/Medxy AIvi2026-09-09T10:31:30-07:00Những yếu tố cản trở tuân thủ sử dụng thiết bị nghe dẫn truyền xương ở trẻ microtia https://news.medxy.ai/ja/incomplete-liver-cirrhosis-impact/Medxy AIja2026-09-09T10:31:17-07:00代償不全肝硬変が心臓手術成績に及ぼす影響：臨床的・経済的意義 https://news.medxy.ai/vi/decompensated-cirrhosis-impact/Medxy AIvi2026-09-09T10:30:58-07:00Xơ gan mất bù ảnh hưởng thế nào đến kết quả phẫu thuật tim? Hệ lụy lâm sàng và kinh tế https://news.medxy.ai/impact-of-decompensated-cirrhosis-on-cardiac-surgery-outcomes-clinical-and-economic-implications/Medxy AIen2026-09-09T10:30:42-07:00Impact of Decompensated Cirrhosis on Cardiac Surgery Outcomes: Clinical and Economic Implications https://news.medxy.ai/zh/liver-trauma-treatment/Medxy AIzh2026-09-09T10:30:31-07:00穿透性肝外伤：血管栓塞治疗与手术如何权衡生存获益和住院时长 https://news.medxy.ai/ja/arterial-embolization-surgery/Medxy AIja2026-09-09T10:30:12-07:00穿通性肝外傷における動脈塞栓術と手術：生存率と入院期間の最適なバランス https://news.medxy.ai/zh/71849-2/Medxy AIzh2026-09-09T10:30:07-07:00成人活体肝移植血管重建的新进展：深部左肝门蒂解剖联合脐部原位解剖 https://news.medxy.ai/vi/angioembolization-vs-surgery/Medxy AIvi2026-09-09T10:29:50-07:00Angioembolization so với phẫu thuật trong chấn thương gan xuyên thấu: Cân bằng giữa sống còn và thời gian nằm viện https://news.medxy.ai/ja/adult-liver-transplantation-vascular-reconstruction/Medxy AIja2026-09-09T10:29:48-07:00成人生体肝移植における血管再建の新展開：in situ 臍部剥離を伴う深部左肝門ペディクル分離 https://news.medxy.ai/vi/liver-transplant-vascular-regeneration/Medxy AIvi2026-09-09T10:29:30-07:00Nâng cao tái tạo mạch máu trong ghép gan từ người hiến sống ở người lớn: Cô lập cuống rốn gan trái sâu kết hợp bóc tách tại chỗ phần rốn của tĩnh mạch cửa https://news.medxy.ai/advancing-vascular-reconstruction-in-adult-living-donor-liver-transplantation-deep-left-hilar-pedicle-isolation-with-in-situ-umbilical-portion-dissection/Medxy AIen2026-09-09T10:29:13-07:00Advancing Vascular Reconstruction in Adult Living Donor Liver Transplantation: Deep Left Hilar Pedicle Isolation with In Situ Umbilical Portion Dissection https://news.medxy.ai/zh/liver-transplant-perfusion-comparison/Medxy AIzh2026-09-09T10:28:42-07:00肝移植中低温氧合灌注与常温机器灌注的真实世界结局比较 https://news.medxy.ai/ja/hypothermic-vs-normothermic-perfusion/Medxy AIja2026-09-09T10:28:23-07:00肝移植における低体温酸素化灌流と常温機械灌流の実臨床成績を比較する https://news.medxy.ai/vi/liver-transplant-blood-flow/Medxy AIvi2026-09-09T10:28:00-07:00So sánh kết cục thực tế của tưới máu ôxy hóa hạ thân nhiệt và tưới máu máy ở nhiệt độ bình thường trong ghép gan https://news.medxy.ai/zh/iga-gut-liver-axis/Medxy AIzh2026-09-09T10:26:52-07:00靶向肠-肝 IgA 轴：缓解酒精相关性肝病中巨噬细胞驱动炎症的新策略 https://news.medxy.ai/ja/iga-axis-alcohol-liver/Medxy AIja2026-09-09T10:26:37-07:00腸-肝IgA軸を標的とした新規戦略：アルコール関連肝疾患におけるマクロファージ駆動性炎症を抑える https://news.medxy.ai/vi/72914-2/Medxy AIvi2026-09-09T10:26:23-07:00 https://news.medxy.ai/zh/dexamethasone-levels/Medxy AIzh2026-09-09T10:25:24-07:001 mg 过夜地塞米松抑制试验中血清地塞米松水平的决定因素：临床与药理学启示 https://news.medxy.ai/ja/dexamethasone-levels/Medxy AIja2026-09-09T10:25:02-07:001 mg夜間デキサメタゾン抑制試験における血清デキサメタゾン濃度の規定因子：臨床・薬理学的考察 https://news.medxy.ai/vi/dexamethasone-levels/Medxy AIvi2026-09-09T10:24:37-07:00Nồng độ dexamethasone huyết thanh trong nghiệm pháp ức chế dexamethasone qua đêm 1 mg: Những yếu tố quyết định và ý nghĩa lâm sàng https://news.medxy.ai/zh/tropical-cyclones-heart-disease/Medxy AIzh2026-09-09T10:21:22-07:00热带气旋与急性冠脉综合征：揭示中国大陆的心血管负担 https://news.medxy.ai/ja/tropical-storm-cardiovascular/Medxy AIja2026-09-09T10:21:05-07:00熱帯低気圧と急性冠症候群：中国本土における心血管負担を読み解く https://news.medxy.ai/zh/avascular-rectus-fascia-graft/Medxy AIzh2026-09-08T10:28:37-07:00无血管化腹直肌筋膜同种异体移植：复杂腹胸部重建的跨学科新策略 https://news.medxy.ai/ja/complex-abdominal-reconstruction/Medxy AIja2026-09-08T10:28:19-07:00複雑な腹部・胸部再建に挑む新手法：無血管性腹直筋筋膜同種移植の可能性 https://news.medxy.ai/vi/abdominal-chest-reconstruction/Medxy AIvi2026-09-08T10:27:59-07:00Mảnh ghép đồng loài mạc cơ thẳng bụng không tưới máu: hướng tiếp cận liên chuyên khoa mới cho tái tạo phức tạp vùng bụng và ngực https://news.medxy.ai/nonvascularized-rectus-fascia-allografts-a-novel-cross-disciplinary-approach-for-complex-abdominal-and-thoracic-reconstruction/Medxy AIen2026-09-08T10:27:41-07:00Nonvascularized Rectus Fascia Allografts: A Novel Cross-Disciplinary Approach for Complex Abdominal and Thoracic Reconstruction https://news.medxy.ai/zh/diverticulitis-quality-life/Medxy AIzh2026-09-08T10:27:01-07:00复发性憩室炎的生活质量与复发评估：一项比较结肠切除术与观察随访的前瞻性多中心研究 https://news.medxy.ai/ja/qol-recurrence-diverticulitis/Medxy AIja2026-09-08T10:26:45-07:00再発性憩室炎におけるQOLと再発を検証：結腸切除術と経過観察を比較した前向き多施設研究 https://news.medxy.ai/vi/quality-of-life-recurrence/Medxy AIvi2026-09-08T10:26:26-07:00Đánh giá chất lượng cuộc sống và tái phát trong viêm túi thừa tái phát: Nghiên cứu tiến cứu đa trung tâm so sánh cắt đại tràng và theo dõi https://news.medxy.ai/evaluating-quality-of-life-and-recurrence-in-recurrent-diverticulitis-a-prospective-multicenter-study-comparing-colectomy-and-observation/Medxy AIen2026-09-08T10:26:09-07:00Evaluating Quality of Life and Recurrence in Recurrent Diverticulitis: A Prospective Multicenter Study Comparing Colectomy and Observation https://news.medxy.ai/zh/postpartum-screening-study/Medxy AIzh2026-09-08T10:25:33-07:00产后6周还是12周更合适？宫颈筛查可行性与诊断表现的配对样本研究 https://news.medxy.ai/ja/postpartum-cervical-screening/Medxy AIja2026-09-08T10:25:18-07:00産後6週・12週の子宮頸部スクリーニングはどこまで有用か：ペアサンプル研究が示した実現可能性と診断成績 https://news.medxy.ai/vi/postpartum-cervical-screening-2/Medxy AIvi2026-09-08T10:25:00-07:00Sàng lọc cổ tử cung sau sinh ở 6 và 12 tuần: tính khả thi và hiệu năng chẩn đoán từ nghiên cứu mẫu ghép đôi https://news.medxy.ai/feasibility-and-diagnostic-performance-of-cervical-screening-at-6-and-12-weeks-postnatal-insights-from-a-paired-sample-study/Medxy AIen2026-09-08T10:24:44-07:00Feasibility and Diagnostic Performance of Cervical Screening at 6 and 12 Weeks Postnatal: Insights from a Paired-Sample Study https://news.medxy.ai/zh/perinatal-pelvic-assessment/Medxy AIzh2026-09-08T10:24:07-07:00验证 ICIQ-PPHSAQ：提升临床实践中围产期盆底功能障碍的评估水平 https://news.medxy.ai/ja/iciq-pphsaq-validation/Medxy AIja2026-09-08T10:23:51-07:00ICIQ-PPHSAQの妥当性検証：周産期の骨盤底機能障害評価を臨床でより正確に https://news.medxy.ai/vi/iciq-pphsq-assessment/Medxy AIvi2026-09-08T10:23:33-07:00Thẩm định ICIQ-PPHSAQ: Nâng cao đánh giá rối loạn chức năng sàn chậu chu sinh trong thực hành lâm sàng https://news.medxy.ai/validating-the-iciq-pphsaq-enhancing-assessment-of-perinatal-pelvic-floor-dysfunction-in-clinical-practice/Medxy AIen2026-09-08T10:23:16-07:00Validating the ICIQ-PPHSAQ: Enhancing Assessment of Perinatal Pelvic Floor Dysfunction in Clinical Practice https://news.medxy.ai/zh/ovary-removal-effects/Medxy AIzh2026-09-08T10:22:42-07:00绝经后良性子宫切除术中卵巢切除的心血管与骨健康结局：基于人群研究的启示 https://news.medxy.ai/ja/ovary-removal-outcomes/Medxy AIja2026-09-08T10:22:23-07:00閉経後女性の良性子宮摘出術における卵巣摘出後の循環器・骨アウトカム：人口ベース研究からの知見 https://news.medxy.ai/vi/ovary-removal-menopause-impact/Medxy AIvi2026-09-08T10:22:03-07:00Cắt bỏ buồng trứng sau cắt tử cung lành tính ở phụ nữ sau mãn kinh: ảnh hưởng đến tim mạch và xương từ một nghiên cứu dựa trên quần thể https://news.medxy.ai/cardiovascular-and-bone-health-outcomes-after-oophorectomy-in-postmenopausal-women-undergoing-benign-hysterectomy-insights-from-a-population-based-study/Medxy AIen2026-09-08T10:21:44-07:00Cardiovascular and Bone Health Outcomes After Oophorectomy in Postmenopausal Women Undergoing Benign Hysterectomy: Insights from a Population-Based Study https://news.medxy.ai/zh/full-term-ultrasound-screening/Medxy AIzh2026-09-08T10:20:58-07:00足月大于胎龄儿的常规超声筛查：如何在诊断局限与干预风险之间取得平衡 https://news.medxy.ai/ja/lga-fetal-ultrasound/Medxy AIja2026-09-08T10:20:39-07:00分娩時期のLGA胎児に対するルーチン超音波スクリーニング：診断限界と介入リスクの両立を考える https://news.medxy.ai/vi/routine-ultrasound-large-term-babies/Medxy AIvi2026-09-08T10:20:19-07:00Sàng lọc siêu âm thường quy đối với thai to đủ tháng: Cân bằng giữa hạn chế chẩn đoán và nguy cơ can thiệp https://news.medxy.ai/routine-ultrasound-screening-for-large-for-gestational-age-fetuses-at-term-balancing-diagnostic-limitations-and-intervention-risks/Medxy AIen2026-09-08T10:20:00-07:00Routine Ultrasound Screening for Large-for-Gestational-Age Fetuses at Term: Balancing Diagnostic Limitations and Intervention Risks https://news.medxy.ai/zh/perinatal-quality-network/Medxy AIzh2026-09-08T10:19:21-07:00全州围产期质量协作网络带来严重孕产妇发病率持续下降并缩小种族差异 https://news.medxy.ai/ja/perinatal-quality-improvement/Medxy AIja2026-09-08T10:19:03-07:00州全体の周産期質改善連携で重篤な母体罹患と人種間格差を持続的に改善 https://news.medxy.ai/vi/reduce-maternal-mortality/Medxy AIvi2026-09-08T10:18:44-07:00Giảm bền vững bệnh suất mẹ nặng và chênh lệch chủng tộc nhờ chương trình hợp tác cải thiện chất lượng chu sinh trên toàn bang https://news.medxy.ai/sustained-reduction-of-severe-maternal-morbidity-and-racial-disparities-through-a-statewide-perinatal-quality-collaborative/Medxy AIen2026-09-08T10:18:27-07:00Sustained Reduction of Severe Maternal Morbidity and Racial Disparities Through a Statewide Perinatal Quality Collaborative https://news.medxy.ai/zh/azithromycin-birth-asphyxia/Medxy AIzh2026-09-08T10:17:44-07:00产时阿奇霉素能否改善出生窒息新生儿的神经发育？——A-PLUS 随访研究提示无明显获益 https://news.medxy.ai/ja/neurodevelopment-outcomes/Medxy AIja2026-09-08T10:17:27-07:00分娩中アジスロマイシン投与後の出生時仮死新生児における神経発達転帰を検証する：A-PLUSフォローアップ研究からの知見 https://news.medxy.ai/vi/neurodevelopment-outcomes-azithromycin/Medxy AIvi2026-09-08T10:17:09-07:00Đánh giá kết cục phát triển thần kinh sau khi dùng azithromycin trong chuyển dạ ở trẻ sơ sinh bị ngạt khi sinh: Góc nhìn từ nghiên cứu theo dõi A-PLUS https://news.medxy.ai/evaluating-neurodevelopmental-outcomes-following-intrapartum-azithromycin-administration-in-neonates-with-birth-asphyxia-insights-from-the-a-plus-follow-up-study/Medxy AIen2026-09-08T10:16:50-07:00Evaluating Neurodevelopmental Outcomes Following Intrapartum Azithromycin Administration in Neonates with Birth Asphyxia: Insights from the A-PLUS Follow-Up Study https://news.medxy.ai/zh/diffusion-mri-brain-small-vessel-disease/Medxy AIzh2026-09-08T10:16:12-07:00弥散 MRI 提前十余年捕捉脑小血管病：白质高信号出现前的临床前期被揭示 https://news.medxy.ai/ja/71762-2/Medxy AIja2026-09-08T10:15:54-07:00拡散MRIが脳小血管病を10年以上早期に検出：白質高信号域出現前の前臨床段階が明らかに https://news.medxy.ai/vi/71760-2/Medxy AIvi2026-09-08T10:15:36-07:00MRI khuếch tán phát hiện bệnh lý mạch máu nhỏ ở não sớm hơn một thập kỷ: Hé lộ giai đoạn tiền lâm sàng trước khi xuất hiện các vùng tăng tín hiệu chất trắng https://news.medxy.ai/early-detection-of-cerebral-small-vessel-disease-diffusion-mri-reveals-a-decade-long-preclinical-phase-before-white-matter-hyperintensities/Medxy AIen2026-09-08T10:15:19-07:00Early Detection of Cerebral Small Vessel Disease: Diffusion MRI Reveals a Decade-Long Preclinical Phase Before White Matter Hyperintensities https://news.medxy.ai/zh/health-social-determinants-stroke/Medxy AIzh2026-09-08T10:14:39-07:00早至中成年期健康社会决定因素与早发性卒中风险：一项全面综述 https://news.medxy.ai/ja/71755-2/Medxy AIja2026-09-08T10:14:22-07:00若年・中年期における健康の社会的決定要因と若年発症脳卒中のリスク：包括的レビュー https://news.medxy.ai/vi/social-determinants-health/Medxy AIvi2026-09-08T10:14:01-07:00Các yếu tố xã hội quyết định sức khỏe ở tuổi trưởng thành sớm đến trung niên và nguy cơ đột quỵ khởi phát sớm: Tổng quan toàn diện https://news.medxy.ai/social-determinants-of-health-in-early-to-mid-adulthood-and-risk-of-early-onset-stroke-a-comprehensive-review/Medxy AIen2026-09-08T10:13:41-07:00Social Determinants of Health in Early to Mid-Adulthood and Risk of Early-Onset Stroke: A Comprehensive Review https://news.medxy.ai/gestational-changes-in-antiseizure-medication-concentrations-and-the-impact-of-polytherapy-insights-from-a-prospective-multicenter-cohort-study-in-china/Medxy AIen2026-09-08T10:11:53-07:00Gestational Changes in Antiseizure Medication Concentrations and the Impact of Polytherapy: Insights from a Prospective Multicenter Cohort Study in China https://news.medxy.ai/zh/immigration-stroke-icu/Medxy AIzh2026-09-08T10:10:54-07:00移民身份与急性卒中 ICU 照护：来自安大略省人群研究的启示 https://news.medxy.ai/ja/immigrant-stroke-icu-care/Medxy AIja2026-09-08T10:10:38-07:00オンタリオ州のデータが示す、移民と急性期脳卒中ICUケアの実像 https://news.medxy.ai/vi/icu-stroke-care/Medxy AIvi2026-09-08T10:10:19-07:00Tình trạng nhập cư và chăm sóc ICU trong đột quỵ cấp: Góc nhìn từ nghiên cứu quần thể ở Ontario https://news.medxy.ai/immigration-status-and-acute-stroke-icu-care-insights-from-ontarios-population-based-study/Medxy AIen2026-09-08T10:10:02-07:00Immigration Status and Acute Stroke ICU Care: Insights from Ontario’s Population-Based Study https://news.medxy.ai/ja/gardnerella-in-pregnancy/Medxy AIja2026-09-08T10:09:28-07:00妊娠糖尿病女性の膣内マイクロバイオームでGardnerellaが増加――胎児出生体重パーセンタイル低値との関連 https://news.medxy.ai/vi/gardnerella-pregnancy-diabetes/Medxy AIvi2026-09-08T10:09:10-07:00Gardnerella tăng trong hệ vi sinh âm đạo ở thai phụ đái tháo đường thai kỳ có liên quan đến phân vị cân nặng sơ sinh thấp hơn https://news.medxy.ai/gardnerella-enrichment-in-the-vaginal-microbiome-of-women-with-gestational-diabetes-mellitus-is-associated-with-lower-fetal-birthweight-percentiles/Medxy AIen2026-09-08T10:08:52-07:00Gardnerella Enrichment in the Vaginal Microbiome of Women with Gestational Diabetes Mellitus Is Associated with Lower Fetal Birthweight Percentiles https://news.medxy.ai/zh/minimed-780g-type-1-diabetes/Medxy AIzh2026-09-08T10:08:10-07:00MiniMed 780G改善老年1型糖尿病患者血糖控制与血管结局：一项随机对照试验 https://news.medxy.ai/ja/minimed-780g-benefits/Medxy AIja2026-09-08T10:07:52-07:00高齢の1型糖尿病患者におけるMiniMed 780G使用後の血糖コントロールと血管転帰の改善：ランダム化比較試験 https://news.medxy.ai/vi/minimed-780g-blood-sugar-control/Medxy AIvi2026-09-08T10:07:31-07:00Cải thiện kiểm soát đường huyết và kết cục mạch máu sau sử dụng MiniMed 780G ở người cao tuổi mắc đái tháo đường type 1: Một thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/improved-glycaemic-control-and-vascular-outcomes-after-minimed-780g-usage-in-older-adults-with-type-1-diabetes-a-randomised-controlled-trial/Medxy AIen2026-09-08T10:07:14-07:00Improved Glycaemic Control and Vascular Outcomes After MiniMed 780G Usage in Older Adults with Type 1 Diabetes: A Randomised Controlled Trial https://news.medxy.ai/zh/cushing-syndrome-elderly-2/Medxy AIzh2026-09-08T10:06:32-07:00老年库欣综合征：老龄化人群中的诊断与治疗要点 https://news.medxy.ai/ja/elderly-cushings-syndrome/Medxy AIja2026-09-08T10:06:14-07:00高齢者のクッシング症候群：加齢を踏まえた診断と治療の要点 https://news.medxy.ai/vi/cushing-syndrome-elderly/Medxy AIvi2026-09-08T10:05:54-07:00Hội chứng Cushing ở người cao tuổi: những điểm cần lưu ý trong chẩn đoán và điều trị https://news.medxy.ai/cushings-syndrome-elderly/Medxy AIen2026-09-08T10:05:24-07:00Cushing’s Syndrome in the Elderly: Diagnostic and Therapeutic Nuances in an Aging Population https://news.medxy.ai/zh/multidimensional-baseline-predict-diabetic-ulcer-risk/Medxy AIzh2026-09-08T10:04:28-07:00多维基线指标助力预测糖尿病足溃疡减压试验脱落风险 https://news.medxy.ai/ja/diabetic-foot-ulcer/Medxy AIja2026-09-08T10:04:11-07:00多領域ベースライン指標を活用した糖尿病性足潰瘍オフローディング試験の脱落予測 https://news.medxy.ai/vi/diabetic-foot-ulcer-risk/Medxy AIvi2026-09-08T10:03:53-07:00Kết hợp các chỉ số nền đa miền để dự báo nguy cơ bỏ cuộc trong thử nghiệm thiết bị giảm tải cho loét bàn chân do đái tháo đường https://news.medxy.ai/harnessing-multidomain-baseline-metrics-to-predict-attrition-in-diabetic-foot-ulcer-offloading-trials/Medxy AIen2026-09-08T10:03:36-07:00Harnessing Multidomain Baseline Metrics to Predict Attrition in Diabetic Foot Ulcer Offloading Trials https://news.medxy.ai/zh/reduce-dka-risk-type-1-diabetes/Medxy AIzh2026-09-08T10:02:59-07:00保留内源性胰岛素生成可显著降低 1 型糖尿病的糖尿病酮症酸中毒风险 https://news.medxy.ai/ja/type-1-diabetes-insulin-preservation/Medxy AIja2026-09-08T10:02:44-07:001型糖尿病では内因性インスリンの温存がDKAリスクを大きく下げる https://news.medxy.ai/vi/preserve-insulin-production/Medxy AIvi2026-09-08T10:02:24-07:00Bảo tồn sản xuất insulin nội sinh giúp giảm rõ rệt nguy cơ nhiễm toan ceton do đái tháo đường ở đái tháo đường type 1 https://news.medxy.ai/preserved-endogenous-insulin-production-significantly-reduces-diabetic-ketoacidosis-risk-in-type-1-diabetes/Medxy AIen2026-09-08T10:02:06-07:00Preserved Endogenous Insulin Production Significantly Reduces Diabetic Ketoacidosis Risk in Type 1 Diabetes https://news.medxy.ai/zh/dnmt3a-variants-pah/Medxy AIzh2026-09-08T10:01:26-07:00DNMT3A胚系与体细胞变异对肺动脉高压的影响：生物标志物与治疗的新方向 https://news.medxy.ai/ja/dnmt3a-pah-impact/Medxy AIja2026-09-08T10:01:05-07:00肺動脈性肺高血圧症におけるDNMT3A生殖細胞系列・体細胞変異の影響：バイオマーカーと治療の新局面 https://news.medxy.ai/vi/71684-2/Medxy AIvi2026-09-08T10:00:44-07:00Tác động của các đột biến dòng mầm và đột biến soma ở gen DNMT3A trong bệnh tăng áp động mạch phổi: Những triển vọng mới về dấu ấn sinh học và liệu pháp điều trị https://news.medxy.ai/impact-of-germline-and-somatic-dnmt3a-variants-on-pulmonary-arterial-hypertension-a-new-frontier-in-biomarkers-and-therapeutics/Medxy AIen2026-09-08T10:00:23-07:00Impact of Germline and Somatic DNMT3A Variants on Pulmonary Arterial Hypertension: A New Frontier in Biomarkers and Therapeutics https://news.medxy.ai/zh/ct-ffrct-accuracy/Medxy AIzh2026-09-08T09:59:42-07:00提升稳定型冠状动脉疾病的诊断准确性：加入CT衍生血流储备分数（FFRct）的影响——FUSION试验解读 https://news.medxy.ai/ja/ct-ffr-diagnosis/Medxy AIja2026-09-08T09:59:21-07:00安定冠動脈疾患の診断精度を高めるには：CT由来FFR追加の意義――FUSION試験からの知見 https://news.medxy.ai/vi/ffrct-diagnosis-enhancement/Medxy AIvi2026-09-08T09:58:57-07:00Nâng cao độ chính xác chẩn đoán trong bệnh động mạch vành mạn tính ổn định: Tác động của việc bổ sung FFRct từ CT – Góc nhìn từ thử nghiệm FUSION https://news.medxy.ai/enhancing-diagnostic-accuracy/Medxy AIen2026-09-08T09:58:39-07:00Enhancing Diagnostic Accuracy in Stable Coronary Artery Disease: Impact of Adding CT-derived Fractional Flow Reserve (FFRct) – Insights from the FUSION Trial https://news.medxy.ai/zh/vivas-coronary-spasm/Medxy AIzh2026-09-08T09:58:01-07:00维利西呱能改善冠状动脉痉挛吗？——ViVA 随机交叉试验带来的启示 https://news.medxy.ai/ja/vericiguat-coronary-spasm/Medxy AIja2026-09-08T09:57:41-07:00冠攣縮に対するベリシグアトの評価：ViVA無作為化クロスオーバー試験からの知見 https://news.medxy.ai/vi/vericiguat-coronary-spasm-2/Medxy AIvi2026-09-08T09:57:20-07:00Đánh giá Vericiguat trong co thắt động mạch vành: Những phát hiện từ thử nghiệm ViVA ngẫu nhiên, bắt chéo https://news.medxy.ai/evaluating-vericiguat-in-coronary-vasospasm-insights-from-the-viva-randomized-cross-over-trial/Medxy AIen2026-09-08T09:57:01-07:00Evaluating Vericiguat in Coronary Vasospasm: Insights from the ViVA Randomized Cross-Over Trial https://news.medxy.ai/zh/tocilizumab-giant-cell-arteritis/Medxy AIzh2026-09-08T09:56:23-07:00托珠单抗可降低巨细胞动脉炎患者主要心血管事件风险：来自法国全国队列研究的启示 https://news.medxy.ai/ja/giant-cell-arteritis-tocilizumab/Medxy AIja2026-09-08T09:56:06-07:00巨細胞性動脈炎でトシリズマブが主要心血管イベントを減少：フランス全国コホートからの知見 https://news.medxy.ai/vi/tocilizumab-heart-risk/Medxy AIvi2026-09-08T09:55:48-07:00Tocilizumab giúp giảm nguy cơ biến cố tim mạch lớn ở viêm động mạch tế bào khổng lồ: dữ liệu từ một đoàn hệ toàn quốc tại Pháp https://news.medxy.ai/tocilizumab-reduces-major-cardiovascular-events-risk-in-giant-cell-arteritis-insights-from-a-nationwide-french-cohort/Medxy AIen2026-09-08T09:55:26-07:00Tocilizumab Reduces Major Cardiovascular Events Risk in Giant Cell Arteritis: Insights from a Nationwide French Cohort https://news.medxy.ai/zh/evolocumab-mortality/Medxy AIzh2026-09-08T09:54:46-07:00Evolocumab 显著降低无既往心梗或卒中高危患者死亡率：VESALIUS-CV 试验的新证据 https://news.medxy.ai/ja/evolocumab-risk-patients/Medxy AIja2026-09-08T09:54:26-07:00エボロクマブは高リスク患者の死亡率を有意に低下させる ― VESALIUS-CV試験が示した、心筋梗塞・脳卒中既往のない患者での新たな知見 https://news.medxy.ai/vi/71651-2/Medxy AIvi2026-09-08T09:54:03-07:00Evolocumab giúp giảm đáng kể tỷ lệ tử vong ở bệnh nhân có nguy cơ cao chưa từng bị nhồi máu cơ tim hoặc đột quỵ: Bằng chứng mới từ thử nghiệm VESALIUS-CV https://news.medxy.ai/evolocumab-significantly-reduces-mortality-in-high-risk-patients-without-prior-heart-attack-or-stroke-insights-from-the-vesalius-cv-trial/Medxy AIen2026-09-08T09:53:42-07:00Evolocumab Significantly Reduces Mortality in High-Risk Patients Without Prior Heart Attack or Stroke: Insights from the VESALIUS-CV Trial https://news.medxy.ai/zh/gildeuretinol-stargardt-safety/Medxy AIzh2026-09-07T10:53:24-07:00gildeuretinol acetate 对 Stargardt 病视网膜萎缩性病灶的安全性与疗效：来自 TEASE-1 随机临床试验的启示 https://news.medxy.ai/ja/gildeuretinol-safety-stargardt/Medxy AIja2026-09-07T10:52:57-07:00Stargardt病における網膜萎縮病変へのGildeuretinol acetateの安全性と効果：TEASE-1無作為化臨床試験からの知見 https://news.medxy.ai/vi/71420-2/Medxy AIvi2026-09-07T10:52:28-07:00Tính an toàn và hiệu quả của Gildeuretinol Acetate đối với các tổn thương teo võng mạc trong bệnh Stargardt: Những thông tin từ thử nghiệm lâm sàng ngẫu nhiên TEASE-1 https://news.medxy.ai/safety-and-effects-of-gildeuretinol-acetate-on-retinal-atrophic-lesions-in-stargardt-disease-insights-from-the-tease-1-randomized-clinical-trial/Medxy AIen2026-09-07T10:52:02-07:00Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: Insights from the TEASE-1 Randomized Clinical Trial https://news.medxy.ai/zh/thyroid-cancer-recurrence/Medxy AIzh2026-09-07T10:51:06-07:00髓样甲状腺癌分区复发新观察：对侧预防性中央区颈清扫是否必要？ https://news.medxy.ai/ja/71411-2/Medxy AIja2026-09-07T10:50:40-07:00甲状腺髄様癌の局所再発に関する新たな知見：対側中心区域頸部リンパ節の予防的郭清は必要か？ https://news.medxy.ai/vi/thyroid-cancer-lymph-node-recurrence/Medxy AIvi2026-09-07T10:50:15-07:00Tái phát hạch theo khoang trong ung thư tuyến giáp thể tủy: Đánh giá vai trò của nạo vét hạch trung tâm dự phòng đối bên https://news.medxy.ai/compartment-specific-nodal-recurrence-in-medullary-thyroid-cancer-evaluating-the-role-of-contralateral-prophylactic-central-neck-dissection/Medxy AIen2026-09-07T10:49:52-07:00Compartment-Specific Nodal Recurrence in Medullary Thyroid Cancer: Evaluating the Role of Contralateral Prophylactic Central Neck Dissection https://news.medxy.ai/protocol-based-early-intensive-lipid-management-significantly-enhances-ldl-c-target-achievement-post-acute-coronary-syndrome-insights-from-the-bridge-trial/Medxy AIen2026-09-07T10:49:31-07:00Protocol-Based Early Intensive Lipid Management Significantly Enhances LDL-C Target Achievement Post-Acute Coronary Syndrome: Insights from the BRIDGE Trial https://news.medxy.ai/zh/optimized-ctdna-monitoring/Medxy AIzh2026-09-07T10:49:12-07:00优化头颈鳞状细胞癌监测：组织指导型ctDNA检测显示出高准确性与良好可行性 https://news.medxy.ai/ja/head-and-neck-cancer-monitoring/Medxy AIja2026-09-07T10:48:50-07:00頭頸部扁平上皮癌のモニタリング最適化：tissue-informed ctDNAアッセイが高精度と実用性を示す https://news.medxy.ai/vi/ctdna-cancer-monitoring/Medxy AIvi2026-09-07T10:48:24-07:00Tối ưu hóa theo dõi ung thư biểu mô tế bào vảy vùng đầu và cổ: Xét nghiệm ctDNA có nguồn gốc từ mô cho thấy độ chính xác cao và tính khả thi tốt https://news.medxy.ai/optimizing-monitoring-in-head-and-neck-squamous-cell-carcinoma-tissue-informed-ctdna-assay-shows-high-accuracy-and-feasibility/Medxy AIen2026-09-07T10:47:56-07:00Optimizing Monitoring in Head and Neck Squamous Cell Carcinoma: Tissue-Informed ctDNA Assay Shows High Accuracy and Feasibility https://news.medxy.ai/zh/hormone-therapy-voice/Medxy AIzh2026-09-07T10:47:13-07:00激素替代治疗会影响嗓音吗？大型 TriNetX 队列揭示围绝经期与绝经后女性的声音障碍风险 https://news.medxy.ai/ja/71396-2/Medxy AIja2026-09-07T10:46:53-07:00ホルモン補充療法は声に影響を及ぼしますか？ https://news.medxy.ai/vi/voice-disorder-risk/Medxy AIvi2026-09-07T10:46:26-07:00Đánh giá nguy cơ rối loạn giọng nói ở phụ nữ tiền mãn kinh và hậu mãn kinh dùng liệu pháp thay thế hormone: Phát hiện từ một đoàn hệ lớn TriNetX https://news.medxy.ai/evaluating-voice-disorder-risks-in-peri-and-post-menopausal-women-using-hormone-replacement-therapy-insights-from-a-large-trinetx-cohort/Medxy AIen2026-09-07T10:46:01-07:00Evaluating Voice Disorder Risks in Peri- and Post-Menopausal Women Using Hormone Replacement Therapy: Insights from a Large TriNetX Cohort